Society of Interventional Oncology

There are only two weeks left to apply to join the SIO Board of Directors! If you’re an SIO member in good standing, this is your chance to make a difference. Submit your application by Friday, 9 August!

Discover more about the open positions: https://bit.ly/3Ukr284

Thank you to everyone who attended the “CATALYZE IR: Building Partnerships Across the MDT” webinar, presented by Boston Scientific We enjoyed the opportunity to participate in the roundtable discussion and gained valuable insights from our faculty on the challenges and successes interventional radiologists (IRs) face when collaborating with multidisciplinary team (MDT) partners.

If you missed the live session, we have great news! An on-demand recording is now available in the SIO Learning Center. Check it out: https://bit.ly/3ydz4qL

We see how bright your dedication to interventional oncology ( ) shines! Participating in our Talk Tuesday's lecture series (yes, even if that means watching all four installments on-demand) was a fantastic step in building a solid foundation for your future projects. Now, it's time to take the next leap!

Apply for the Young IO Research Fellowship Award and/or the Abstract Travel Award. This is your opportunity to gain the recognition you deserve. Don’t miss out – put forth an application by Thursday, 22 August.

Learn more and apply: https://bit.ly/46fDdH6

Exciting News! 🎉

SIO’s 2023 requested changes to the National Comprehensive Cancer Network (NCCN)’s Sarcoma Guideline have been incorporated. Recent updates to the 2024 National Comprehensive Cancer Network (NCCN)’s Sarcoma Guidelines now include the following interventional oncology interventions:

1. The addition of transarterial chemoembolization (TACE) as a treatment option for selective extra-abdominal desmoid tumors;
2. Clarifying embolization procedures to include transarterial bland embolization, chemoembolization, and radioembolization for non-lung metastases treatment.

This is a significant milestone for the field of interventional oncology ( ). A huge thank you to our Sarcoma Guideline task force members:

• Jack Jennings, MD, PhD
• Joseph Erinjeri, MD, PhD
• Daehee Kim, MD
• Amy Deipolyi, MD, PhD, FSIR, SIO NCCN Sub-Committee Chair

Through our partnership with the Society of Interventional Radiology on this advocacy effort, we strive to refine the NCCN's guidelines for kidney, soft tissue sarcoma, breast cancer, pancreatic adenocarcinoma care, and more. Learn more about our efforts to advance Interventional Oncology (IO) as the fourth pillar of cancer therapy through advocating for IO therapies in the NCCN guidelines here: https://bit.ly/46pyiCp

Don't forget to join us for the 2024 Regional MSK Master Class on 4-5 October at Beth Israel Deaconess Medical Center/Harvard Medical School. This will be your opportunity to hear from experts and course directors: Jack Jennings, MD, PhD, FSIR; Sean M. Tutton, MD, FSIR, FCIRSE; and Marwan Moussa, MD.

Get ready to enhance your skills in musculoskeletal interventions! Register now: https://bit.ly/3KaOzC5

Still not registered for tomorrow’s webinar? Hurry! This is your last chance to join us for “CATALYZE IR: Building Partnerships Across the MDT,” Presented by Boston Scientific. Live attendees will have the opportunity to be part of a roundtable discussion and hear from our faculty on the challenges and successes interventional radiologists (IRs) face when collaborating with multidisciplinary team (MDT) partners.

📅 Tuesday, 16 July 2024
⏰ 7 p.m. ET

Register before is too late: https://bit.ly/3VFD9f1

Great news! SIO is seeking passionate leaders to join our Board of Directors. If you’re an SIO member in good standing, this is your chance to make a difference. Interested in serving with our board leadership? Submit your application by Friday, 9 August!

Learn more about the open positions: https://bit.ly/3Ukr284

Tomorrow! Don’t miss out on the second webinar in the 2024 Talk of the Season series: "How to Approach the Job Search," hosted by the SIO Resident and Medical Student Section (RMSS).

This informational session is perfect for trainees beginning their job search journey. We’ll have a panel of attendees from both academic and private practice settings, eager to share their insights and tips. Come prepared with your questions and get ready to hear from expert faculty on how to successfully navigate the job hunt!

Thank you to AstraZeneca and Varian for sponsoring this webinar!

There’s still time to register: https://bit.ly/4eJgS8W

Next Week! Join us on Tuesday, 16 July, at 7 p.m. ET for “CATALYZE IR: Building Partnerships Across the MDT.” Don't miss this roundtable discussion where faculty will explore the challenges and successes interventional radiologists (IRs) face when collaborating with multidisciplinary team (MDT) partners.

Special thanks to Boston Scientific for presenting this webinar!

Register here to secure your spot: https://bit.ly/3VFD9f1

Still thinking about becoming an SIO member? Great news! You can now purchase an Extended Membership with SIO, ensuring you maintain access to exclusive member discounts, education, and resources through 2025. As a member, you can connect with an international network of interventional oncology ( ) experts and take advantage of tools designed to help you advance your career and the profession.

Learn more and become an SIO member now: https://bit.ly/3MvVgR1

The SIO Resident and Medical Student Section (RMSS) is excited to present its second webinar in the 2024 Talk of the Season series next week: "How to Approach the Job Search" on Thursday, 11 July, at 7 p.m. ET.

This session is ideal for trainees embarking on their job search, and will feature panelists from both academic and private practice backgrounds, ready to share their valuable insights and advice. Bring your questions and prepare to learn from expert faculty about successfully navigating the job market!

Register here: https://bit.ly/4eJgS8W

The Society of Interventional Oncology submitted updates to the NCCN Guidelines of Colon and Re**al Cancer. Authored by Bruno C. Odisio, MD, PhD, FSIR (lead author); Kamran Ahrar, MD; Juan Camacho, MD; and Ahmad Parvinian, MD, this letter requests specific changes to the NCCN Colon and Re**al Cancer Guidelines, including the acknowledgment of recent data demonstrating the improved outcomes of thermal ablation over surgery for select patients with small colorectal cancer liver metastases; clarification of the distinction between image-guided thermal ablation and other local therapies such as SBRT; and the creation of a specific “Principles of Locoregional Therapy” section. Additionally, the letter requests an increased number of interventional radiologists (IRs) on the panel.

Download the complete letter here: https://bit.ly/46pyiCp

In July, we are recognizing Bone Cancer and Sarcoma Awareness Month. Interventional oncology ( ) plays a critical role in the management of sarcoma and bone cancer by providing diagnostic accuracy, effective localized treatments, pain relief, and improved quality of life for patients. It complements traditional oncology approaches like surgery, chemotherapy, and radiation therapy, offering a comprehensive, multidisciplinary approach to cancer care.

Learn more and stay informed about ways to prevent and treat bone cancer and sarcoma: https://bit.ly/3CVMczo

Mark your calendars!

Make plans to join us for the SIO 2025 Annual Scientific Meeting, where innovation meets excellence in interventional oncology ( ) research.

📍 Location: Las Vegas, Nevada
🗓️ Dates: 30 January – 3 February 2025

Stay tuned for more details! Registration will open this fall. https://bit.ly/4bd1UF8

Join us on Tuesday, 16 July, at 7 p.m. ET for the webinar, “CATALYZE IR: Building partnerships across the MDT A roundtable discussion on effectively integrating Y-90 with your MDT.” Hear from our invited faculty Edward Kim, MD, FSIR; Evan Lehrman, MD, FSIR; Tyler Sandow, MD; and Nora Tabori, MD.

Thank you, Boston Scientific, for supporting this webinar.

Register today: https://bit.ly/3VFD9f1

The SIO Resident and Medical Student Section (RMSS) is thrilled to host the second webinar in the 2024 Talk of the Season series: "How to Approach the Job Search."

🗓 Date: Thursday, 11 July
🕖 Time: 7 p.m. ET

This informational session is perfect for trainees beginning their job search journey. We’ll have a panel of attendees from both academic and private practice settings, eager to share their insights and tips. Come prepared with your questions and get ready to hear from the expert faculty on how to successfully navigate the job hunt!

Don't miss out – mark your calendars and join us for this invaluable session! Register here: https://bit.ly/4eJgS8W

Thank you to all who attended our Talk Tuesdays series. We hope you had an opportunity to improve your ability to read and understand research content in scientific publications. We can’t wait to repeat it all over again next year!

Recordings are now available in the SIO Learning Center. Head there now to catch anything you missed! Remember, by participating in the full series (yes, even if that means watching all four installments on-demand) you could be eligible for the Abstract Travel Award and the Young IO Research Fellowship Award.

Watch the recordings now: https://bit.ly/3VVp2Ua

Get ready for the final Talk Tuesday of the season!

Join us on Tuesday, 25 June, at 7 p.m. ET for “Oncologic Imaging and Imaging Biomarker Studies.” Don’t miss your chance to participate in this FREE webinar series and enhance your ability to interpret scientific research.

Register now: https://bit.ly/3yRjfpM

Special thanks to Varian for supporting Talk Tuesdays.

In June, we are recognizing Cancer Immunotherapy Month. Join us in celebrating the transformative power and vast potential of immunotherapy in revolutionizing cancer treatment.

At SIO, we are dedicated to raising awareness and informing people about the promise and progress of immunotherapy, a cutting-edge approach that is transforming lives. Learn more about how you can support: https://bit.ly/3x9nlJo

This , it is crucial to reflect and create awareness in honor of all cancer survivors. At SIO, we understand the unique path that patients encounter before, during, and after treatment.

SIO is committed to acknowleding the patient story in someone's journey, and we for all patients and those connected to them.

This June, take a moment to support cancer survivors, those who are still on their journey, and remember the ones who have passed. Learn more about National Cancer Survivor Month here: https://bit.ly/3JtK71w

Learn how to establish the “collaborative benchmark” between interventional and medical across all stages of hepatocellular ( ) with this Seminars & Tumor Board PeerView educational activity developed in collaboration with the Society of Interventional Oncology, which utilizes case studies from the panelists' practices to explore the roles of IRs and medical oncologists in HCC care. Hear strategies for how to combine forces for multidisciplinary decision-making, including managing intermediate-stage HCC with LRT and immunotherapy. Additionally, hear expert insights on the latest evidence supporting immunotherapy combinations across various stages and presentations of HCC. https://bit.ly/3TsA54L

Establishing the Collaborative Benchmark for HCC Care: Critical Discussions Between Interventional Radiologists and Oncologists to Maximize Therapeutic Benefit I participated in “The Collaborative Benchmark for HCC: Critical Discussions Between IR–Oncology Professionals,” a CME/MOC activity from

Ready for the next installment in our “Talk Tuesdays” series? Make sure to join us on Tuesday, 18 June at 7 p.m. E.T for the next webinar on “Tumor Microenvironments and Cancer Immunology.” Don’t miss out on this free opportunity to improve your ability to read and understand research content in scientific publications.

Register now: https://bit.ly/3yRjfpM

Reminder that registration is officially open for the 2024 Regional MSK Master Class, taking place 4-5 October at Beth Israel Deaconess Medical Center/Harvard Medical School. This intensive program will feature a mix of didactic lectures and hands-on learning, led by course directors Jack Jennings, MD, PhD, FSIR, Sean M. Tutton, MD, FSIR, FCIRSE, and Marwan Moussa, MD.

Don’t miss out on the opportunity to hear from experts and enhance your skills in musculoskeletal interventions. Register now: https://www.sio-central.org/Events/MSK-Master-Class/Registration

Mark your calendars! The next installment of SIO's "Talk Tuesdays" series is happening tomorrow, 11 June at 7 p.m. ET.

Join us for "AI in IR: Nuts and Bolts, and How to Evaluate an AI Paper," a FREE, educational lecture designed to help early-career interventional radiologists enhance their research skills. Don't miss out on this opportunity to advance your understanding of AI in Interventional Radiology!

Register now: https://bit.ly/3yRjfpM

Thank you to all who attended the 2024 Y90 Master Class! And a big thank you to our Premier Hands-On Course Partners, Boston Scientific and Sirtex, as well as our Supporting Partners, AstraZeneca, Eisai Global, and Genentech for helping make this year's event such as success 🎉

We can't wait to see you next year. Save travels back home!

That's a wrap for day one of the Y90 Master Class! We can't wait to see you tomorrow for day two.

Welcome to the 2024 Y90 Master Class! Take a look at how we are spending day one at the University of Chicago Gleacher Center.

As we get ready to welcome attendees to the 2024 Y90 Master Class, we want to take a moment to thank our premier hands-on course partners and supporting partners! Their generous support helps bring these programs to life!

Boston Scientific , Sirtex Medical, AstraZeneca, Eisai Global and Genentech

Exciting news! You can now purchase an Extended Membership with SIO, ensuring your access to exclusive member discounts, education and resources through 2025. But hurry!

As a member, you can connect with an international network of interventional oncology (IO) experts and gain access to cutting-edge research and resources designed to help you advance your career and the IO profession as a whole.

Learn more and join SIO here: now: https://bit.ly/3MvVgR1

We're proud to announce that the Gustave Roussy Cancer Center, France, has been approved for enrollment and is now activated for SIO's ACCLAIM Clinical Trial. This marks the fourth European site activated and the ninth site overall for the project. Thierry de Baere, MD, will serve as Principal Investigator for the study site with Frederic Deschamps, MD, Lambros Tselikas, MD, and Baptiste Bonnet, MD, as co-investigators. Read the full press release here: https://bit.ly/4bHDm8d